High Cardiovascular Risk Profile in Young Patients on the Kidney Transplant Waiting List

被引:1
作者
Muelling, Nils [1 ]
Kallenberg, Nico [1 ]
Benson, Sven [2 ]
Dolff, Sebastian [3 ]
Kribben, Andreas [1 ]
Reinhardt, Walter [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Hufelandstr 55, D-45122 Essen, Germany
[2] Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Univ Hosp Essen, Essen, Germany
[3] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany
关键词
C-REACTIVE PROTEIN; URIC-ACID; SERUM-ALBUMIN; DIALYSIS PATIENTS; HEMOGLOBIN LEVEL; LDL CHOLESTEROL; DISEASE; INFLAMMATION; MORTALITY; PREVALENCE;
D O I
10.1016/j.transproceed.2019.04.055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Cardiovascular complications are the leading causes of morbidity and mortality in patients with end-stage renal disease. The risk profile very often contributes to their death while on the waiting list. Most studies have been carried out in older patients with end-stage renal disease, reflecting the general dialysis population. The aim of this study was to analyze the risk profile in young patients with advanced chronic kidney disease on the kidney transplant waiting list. Methods. This was a retrospective, single-center study of 748 patients on the kidney transplant waiting list at the University Hospital Essen, Germany. Clinical and laboratory parameters were collected between 2015 and 2016. Results. Of 748 patients (62% male), the median age was 48 years. Hypertension, coronary heart disease, and diabetes mellitus were the leading comorbidities, and their frequency rose significantly with age. Their median laboratory values did not differ significantly depending on age except for albumin. Hyperuricemia was quite common in our population with a prevalence of about 75% in women and 50% in men throughout all age groups. A total of 26.6% of the patients between 18 and 35 years of age had advanced anemia (hemoglobin < 10 g/dL), and thus they were affected most frequently. Elevated C-reactive protein serum levels were observed in 37.2% of the patients. Regarding the lipid profile, we observed that HDL cholesterol was within the normal range in only among 51.9% of men and 44.3% of women. Conclusions. Cardiovascular risk factors are quite common in our cohort and affect young patients similarly.
引用
收藏
页码:1717 / 1726
页数:10
相关论文
共 67 条
  • [1] Effect of anemia correction to the modestly high hemoglobin level in patients with chronic kidney disease on left ventricular hypertrophy
    Akaishi, Makoto
    Hiroe, Michiaki
    Hada, Yoshiyuki
    Suzuki, Makoto
    Tsubakihara, Yoshiharu
    Akizawa, Tadao
    [J]. JOURNAL OF CARDIOLOGY, 2013, 62 (3-4) : 249 - 256
  • [2] Update on Inflammation in Chronic Kidney Disease
    Akchurin, Oleh M.
    Kaskel, Frederick
    [J]. BLOOD PURIFICATION, 2015, 39 (1-3) : 84 - 92
  • [3] Impact of Patient Characteristics and Comorbidity Profile on Activation of Patients on the Kidney Transplantation Waiting List
    Akolekar, D.
    Forsythe, J. L. R.
    Oniscu, G. C.
    [J]. TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2115 - 2122
  • [4] Antunes Sandra Azevedo, 2016, Braz. J. Nephrol., V38, P70, DOI 10.5935/0101-2800.20160011
  • [5] Mechanisms of Anemia in CKD
    Babitt, Jodie L.
    Lin, Herbert Y.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1631 - 1634
  • [6] Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
    Babitt, Jodie L.
    Lin, Herbert Y.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : 726 - 741
  • [7] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
    Baigent, Colin
    Landray, Martin J.
    Reith, Christina
    Emberson, Jonathan
    Wheeler, David C.
    Tomson, Charles
    Wanner, Christoph
    Krane, Vera
    Cass, Alan
    Craig, Jonathan
    Neal, Bruce
    Jiang, Lixin
    Hooi, Lai Seong
    Levin, Adeera
    Agodoa, Lawrence
    Gaziano, Mike
    Kasiske, Bertram
    Walker, Robert
    Massy, Ziad A.
    Feldt-Rasmussen, Bo
    Krairittichai, Udom
    Ophascharoensuk, Vuddidhej
    Fellstrom, Bengt
    Holdaas, Hallvard
    Tesar, Vladimir
    Wiecek, Andrzej
    Grobbee, Diederick
    de Zeeuw, Dick
    Gronhagen-Riska, Carola
    Dasgupta, Tanaji
    Lewis, David
    Herrington, William
    Mafham, Marion
    Majoni, William
    Wallendszus, Karl
    Grimm, Richard
    Pedersen, Terje
    Tobert, Jonathan
    Armitage, Jane
    Baxter, Alex
    Bray, Christopher
    Chen, Yiping
    Chen, Zhengming
    Hill, Michael
    Knott, Carol
    Parish, Sarah
    Simpson, David
    Sleight, Peter
    Young, Alan
    Collins, Rory
    [J]. LANCET, 2011, 377 (9784) : 2181 - 2192
  • [8] C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients
    Bazeley, Jonathan
    Bieber, Brian
    Li, Yun
    Morgenstern, Hal
    de Sequera, Patricia
    Combe, Christian
    Yamamoto, Hiroyasu
    Gallagher, Martin
    Port, Friedrich K.
    Robinson, Bruce M.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10): : 2452 - 2461
  • [9] Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
    Bellomo, Gianni
    Venanzi, Sandro
    Verdura, Claudio
    Saronio, Paolo
    Esposito, Antonella
    Timio, Mario
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (02) : 264 - 272
  • [10] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590